BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ayrignac X, Bilodeau P, Prat A, Girard M, Labauge P, Le Lorier J, Larochelle C, Duquette P. Assessing the risk of multiple sclerosis disease-modifying therapies. Expert Review of Neurotherapeutics 2019;19:695-706. [DOI: 10.1080/14737175.2019.1627201] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Papeix C, Donze C, Lebrun-Frénay C; French Group for Recommendations in Multiple Sclerosis (France4MS), the Société Francophone de la Sclérose En Plaques (SFSEP)., Co-Chairs., Group of evaluators Coordinators., Readers., Cotator., Expert readers (voters). Infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society. Rev Neurol (Paris) 2021:S0035-3787(21)00602-0. [PMID: 34303537 DOI: 10.1016/j.neurol.2021.04.011] [Reference Citation Analysis]
2 Kingwell E, Zhang T, Zhu F, Walld R, Carruthers R, Evans C, Marrie RA, Tremlett H. Short-term laboratory and related safety outcomes for the multiple sclerosis oral disease-modifying therapies: an observational study. Expert Opin Drug Saf 2021;20:481-7. [PMID: 33342303 DOI: 10.1080/14740338.2021.1867536] [Reference Citation Analysis]
3 Reyes-Mata MP, Rojas-Mayorquín AE, Carrera-Quintanar L, González-Castillo C, Mireles-Ramírez MA, Guerrero-García JJ, Ortuño-Sahagún D. Pleiotrophin serum level is increased in Relapsing-Remitting Multiple Sclerosis and correlates with sex, BMI and treatment. Arch Med Res 2021:S0188-4409(21)00140-5. [PMID: 34247888 DOI: 10.1016/j.arcmed.2021.06.005] [Reference Citation Analysis]
4 Freedman MS, Devonshire V, Duquette P, Giacomini PS, Giuliani F, Levin MC, Montalban X, Morrow SA, Oh J, Rotstein D, Yeh EA. Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group Recommendations. Can J Neurol Sci 2020;47:437-55. [DOI: 10.1017/cjn.2020.66] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]